Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC
Conditions: Premenopausal Breast Cancer; Metastatic Breast Cancer; ER Positive Breast Cancer Interventions: Drug: Goserelin; Drug: Fulvestrant; Drug: Capivasertib; Drug: Durvalumab Sponsor: National Taiwan University Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Hormonal Therapy | Hormones | Hospitals | Immunotherapy | Research